Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 2:12 AM ET


Company Overview of Geron Bio-Med

Company Overview

Roslin Bio-Med develops biomedical opportunities concentrating on applications in xenotransplantation. The comapny's initial targets included the cloning of pigs by nuclear transfer and the creation of genetically modified pigs in which a key gene, alpha-1-galactosyl transferase, was eliminated. Roslin Bio-Med was founded in 1998 and is based in Scotland, U.K. Roslin Bio-Med will operate as Geron Bio-Med. As of 05/04/1999, Roslin Bio-Med is a subsidiary of Geron Corp.


United Kingdom

Founded in 1998

Key Executives for Geron Bio-Med

Chief Executive Officer
Age: 58
Manager of Business Development
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Autism Therapeutics Ltd. Europe
Epsom Glass Industries Limited Europe
Oval Medical Technologies Limited Europe
Vetdermal Systems Limited Europe
Bactevo Ltd Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Geron Bio-Med, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at